Ertugliflozin in the treatment of type 2 diabetes mellitus
This narrative review aims to present and discuss the efficacy, safety, cardiovascular, and renal outcomes related to the use of ertugliflozin in Type 2 diabetes.
Overall, this analysis highlights gaps in our knowledge regarding the optimal use of bilastine. Expert opinion based upon an understanding of the science can help in the decision-making, but more research is needed to provide evidence-based answers in certain circumstances.